标题
E2F1-dependent oncogenic addiction of melanoma cells to MDM2
作者
关键词
-
出版物
ONCOGENE
Volume 31, Issue 7, Pages 828-841
出版商
Springer Nature
发表日期
2011-07-11
DOI
10.1038/onc.2011.277
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mdm2 and PCAF increase Chk2 ubiquitination and degradation independently of their intrinsic E3 ligase activities
- (2011) Elizabeth M. Kass et al. CELL CYCLE
- Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia
- (2010) J. Long et al. BLOOD
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cellular quiescence caused by the Mdm2 inhibitor Nutlin-3A
- (2010) Lioubov G. Korotchkina et al. CELL CYCLE
- Nutlin-3a Induces Cytoskeletal Rearrangement and Inhibits the Migration and Invasion Capacity of p53 Wild-Type Cancer Cells
- (2010) Diarmuid M. Moran et al. MOLECULAR CANCER THERAPEUTICS
- p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
- (2010) Tamara Terzian et al. Pigment Cell & Melanoma Research
- The p53 orchestra: Mdm2 and Mdmx set the tone
- (2010) Mark Wade et al. TRENDS IN CELL BIOLOGY
- DNA damage response to the Mdm2 inhibitor Nutlin-3
- (2009) Rajeev Verma et al. BIOCHEMICAL PHARMACOLOGY
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
- (2009) Wei Fu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacologic p53 Activation Blocks Cell Cycle Progression but Fails to Induce Senescence in Epithelial Cancer Cells
- (2009) B. Huang et al. MOLECULAR CANCER RESEARCH
- Ribosomal Protein S7 Is Both a Regulator and a Substrate of MDM2
- (2009) Yan Zhu et al. MOLECULAR CELL
- A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging
- (2009) Matilde Murga et al. NATURE GENETICS
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells
- (2008) H. Shen et al. CANCER RESEARCH
- Nutlin-3a Activates p53 to Both Down-regulate Inhibitor of Growth 2 and Up-regulate mir-34a, mir-34b, and mir-34c Expression, and Induce Senescence
- (2008) K. Kumamoto et al. CANCER RESEARCH
- Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin
- (2008) K. A. Avery-Kiejda et al. CLINICAL CANCER RESEARCH
- Cellular senescence in vivo: a barrier to tumorigenesis
- (2008) Alexandre Prieur et al. CURRENT OPINION IN CELL BIOLOGY
- The genetics of the p53 pathway, apoptosis and cancer therapy
- (2008) Alexei Vazquez et al. NATURE REVIEWS DRUG DISCOVERY
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started